Skip to main content

Closed

MRNA: Moderna, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-39.2% / yr

Operating margin-149.0%

ROIC-39.4%

Financially safe

Stretched

Debt / equity0.18×

Interest coverage-415.0×

Current ratio2.29×

Moderna, Inc.

MRNANASDAQ·USD·Closed

Moderna, Inc.

MRNANASDAQ·USD·Closed

$54.82

−5.35%

$54.82

−$3.10 (5.35%)

52W Range

51thpctl

Volume

1.01×avg

Mkt Cap

21.75BUSD

P/E

-6.9TTM

Div Yield

–ann

52W Range

51thpctl

Volume

1.01×avg

Market Cap

21.75BUSD

P/E Ratio

-6.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings